Please enable JS

ARTICLES & TESTIMONIALS

FILTER BY TYPE

Most Recent

Categories

ARCHIVES

Washington State Wire – Op/Ed – Biosimilar Drugs Require More Transparent Communication Between Patient and Pharmacist: SB 5935 Needs Work

Jul 10/50SN Staff/ GHLF in the news

Very recently during the 64th Legislature in the State of Washington, House Bill 1675 was introduced relating to the prescription of biological products and interchangeable biological products.

READ MORE

DENVER BUSINESS JOURNAL – Cheaper generic biotech drugs loom as ‘biosimilars’ law advances in Colorado Legislature

Jul 10/50SN Staff/ Advocates in the news

The U.S. Food & Drug Administration approved the first generic version of a biotech drug for domestic sale Friday, hours after Colorado state legislators wrestled with how to let pharmacists handle cheaper biotech drug knockoffs.

READ MORE

Victory in Louisiana

Jul 07/50SN Staff/ Victories

Patient advocates Kat Macfarlane and Candice Dusset were integral in the passing of Louisiana House Bill 319, which was signed into law on July 1st!

READ MORE

Department of Health and Human Services letter

Jul 03/50SN Staff/ Letters and Testimony

Dear Mr. Ginsberg,

Thank you for your June 12, 2015, letter to Acting Commissioner Ostroff on behalf of the Global Healthy Living Foundation regarding the labeling of biosimilars. Your letter was forwarded to the Center for Drug Evaluation and Research for response.

READ MORE

Facebook: Free, until it isn’t

Jun 30/50SN Staff/ GHLF in the news

A recent decision by Facebook to limit the content we see in our newsfeeds could have far-­reaching
and potentially deleterious unintended consequences for the global nonprofit and advocacy
communities.

READ MORE